Chief Financial Officer and Chief Business Officer
Brian has over 20 years of experience in the healthcare industry and has held senior leadership positions in several pharmaceutical companies. He previously co-founded and served as chief business officer of Hawkeye Therapeutics and served as chief business officer at Laguna Pharmaceuticals and as vice president of corporate development and operations at Sequel Pharmaceuticals. Prior to Sequel, he was responsible for corporate development at NovaCardia until its acquisition by Merck & Co., Inc., in 2007. Before this, he was a global marketing associate at Eli Lilly and worked in marketing and sales operations for Prudential HealthCare and in public health program management. Brian is also an entrepreneur-in-residence at Frazier Healthcare Partners.
He earned his M.B.A. from the University of Texas and his B.S. from Trinity University.